Form 4: Astera Labs CEO Jitendra Mohan Executes Stock Sale

Astera Labs CEO Jitendra Mohan sold approximately 140,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Summary

• CEO Jitendra Mohan sold a total of 140,000 shares of Astera Labs (ALAB) common stock on May 18 and May 19, 2026.
• The transactions were executed automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025.
• Shares were sold at weighted average prices ranging from approximately $210.67 to $250.00 per share.
• The shares sold were held indirectly by a Living Trust, of which the CEO serves as a trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; while insider selling can be optically negative, the use of a pre-planned 10b5-1 schedule indicates these sales were scheduled months in advance for liquidity purposes.

Positives

• The sales were conducted pursuant to a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.

Negatives

• Significant insider selling by the CEO may be perceived negatively by retail investors as a signal of potential valuation concerns or profit-taking.

Risks

• Continued insider selling could exert downward pressure on the stock price.
• Market perception of executive confidence may be impacted by the reduction in direct and indirect holdings.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing, as it is a standard disclosure of insider transaction activity.

Industry Context

StockSavvy.ai notes that routine 10b5-1 sales by high-level executives in the semiconductor and high-growth tech sectors are common and typically reflect personal financial planning rather than a change in corporate strategy or outlook.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for executives at major tech firms like NVIDIA, AMD, and Intel to manage equity compensation.
• The volume of shares sold relative to the CEO's total holdings remains a small fraction of his overall beneficial ownership.

Stakeholder Impact

• Shareholders should note the reduction in the CEO's indirect stake, though the CEO maintains significant beneficial ownership across multiple trusts.

Next Steps

• Monitor future Form 4 filings to track the remaining duration and volume of the 10b5-1 trading plan.

Key Dates

Recommendation

The filing represents routine executive liquidity management via a pre-planned 10b5-1 program. It does not signal a change in company fundamentals or management's outlook on the business.

Keywords

Astera Labs, ALAB, Insider Selling, Jitendra Mohan, 10b5-1, SEC Form 4